GHRP-2 5 mg: Potent Growth Hormone Secretagogue for Performance Research
Dragon Pharma presents GHRP-2 5 mg, a powerful growth hormone-releasing peptide that has become a cornerstone of performance enhancement and body composition research. This third-party tested compound (verified 5.88 mg actual content) offers researchers a potent tool for studying natural growth hormone optimization without the significant hunger stimulation associated with other GHRPs. With its balanced profile and reliable GH-releasing properties, Dragon Pharma GHRP-2 provides exceptional research opportunities in muscle growth, fat loss, recovery enhancement, and overall metabolic optimization through physiological GH pulsatility.
DRUG DESCRIPTION
Dragon Pharma’s GHRP-2 is supplied as a sterile, lyophilized powder in a 5 mg / 2 mL vial, with independent laboratory analysis confirming 5.88 mg actual content (test date: 2025-11-07). GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide (D-Ala-D-βNal-Ala-Trp-D-Phe-Lys-NH2) that functions as a potent ghrelin receptor (GHSR-1a) agonist. The peptide stimulates pituitary somatotroph cells to release stored growth hormone through multiple mechanisms, including direct receptor activation and somatostatin inhibition. Unlike natural ghrelin, GHRP-2 has been structurally modified to resist enzymatic degradation, resulting in enhanced stability and prolonged activity. Its primary advantage lies in its ability to produce robust GH pulses with minimal effects on cortisol and prolactin compared to other secretagogues, and significantly less hunger stimulation than GHRP-6. This makes GHRP-2 particularly valuable for research protocols where appetite control is important alongside GH optimization.
GHRP-2 PROFILE
Drug Class: Growth Hormone Releasing Peptide
Main Active Substance: GHRP-2
Concentration: 5 mg/vial
Presentation: Lyophilized powder in 2 mL vial
Elimination Half-Life: ~15-30 minutes
Recommended Dosage: 100-300 mcg 2-3 times daily
Anabolic Ratio: N/A (works through GH release)
Androgenic Ratio: N/A
Acne: None (though GH increase may cause temporary skin oiliness)
Hepatotoxicity: None
Aromatization: No
Manufacturer: Dragon Pharma
LAB TEST REPORT
Dragon Pharma maintains exceptional quality standards through rigorous third-party testing, as demonstrated by the GHRP-2 laboratory analysis conducted on November 7, 2025. The testing verified that our GHRP-2 5 mg vials contain 5.88 mg of active substance, representing a remarkable 117.6% potency confirmation that significantly exceeds the labeled amount.
The analysis utilized advanced liquid chromatography-mass spectrometry (LC-MS) methodology to ensure precise quantification and confirm peptide sequence integrity. This substantial overfill provides researchers with exceptional value and dosing flexibility, while the independent verification ensures consistent, reproducible results in growth hormone research studies where dosing accuracy directly impacts pituitary response and study outcomes.
HOW TO USE GHRP-2
For research purposes, GHRP-2 5 mg is reconstituted with bacteriostatic water. Research protocols typically involve administration 2-3 times daily due to the peptide’s relatively short half-life, with common timing including upon waking, pre-workout, and before bedtime. Administration should occur on an empty stomach, as food intake—particularly carbohydrates—can significantly blunt the GH response. Research cycles commonly last 12-16 weeks due to the excellent safety profile, often followed by 4-8 week breaks. GHRP-2 is frequently researched in sophisticated peptide stacks for enhanced effects. It combines powerfully with CJC-1295 DAC for sustained 24-hour GH elevation research. For cutting phase studies, it pairs effectively with AOD 9604 5 mg for enhanced fat loss through complementary mechanisms. During mass building phases with compounds like Dianabol 50, GHRP-2 provides natural GH support for quality muscle accumulation. For recovery enhancement, it can be stacked with BPC-157 for comprehensive tissue repair. For researchers studying nutrient partitioning, it pairs well with L-Carnitine 500 for optimized metabolic effects.
POSSIBLE SIDE EFFECTS
GHRP-2 is generally well-tolerated in research settings, with side effects typically being mild and transient. The most common effects include mild facial flushing, tingling sensations, or temporary lethargy following administration, which are consistent with acute GH release. Some research subjects report mild hunger stimulation, though this is significantly less pronounced than with GHRP-6. Unlike Hexarelin, GHRP-2 has minimal effects on cortisol and prolactin levels at standard research doses. Some researchers note temporary joint stiffness or water retention as IGF-1 levels increase, particularly during the initial adaptation period. Injection site reactions are rare with proper technique. The substantial overfill and verified purity of Dragon Pharma’s formulation ensure researchers avoid the variability that can occur with underdosed compounds, which could lead to inconsistent pituitary responses and unreliable research outcomes.
CONCLUSION
Dragon Pharma’s GHRP-2 5 mg represents a premium research tool for growth hormone optimization studies, offering verified potency and substantial overfill for exceptional value and dosing precision. Its balanced profile—providing robust GH release with minimal hunger stimulation and favorable effects on other hormones—makes it particularly valuable for body composition research and performance optimization studies. The third-party verified 117.6% potency ensures researchers receive exceptional value while maintaining precise control over pituitary stimulation in their studies. When implemented within structured research protocols that account for its short half-life and include proper fasting periods before administration, GHRP-2 can yield significant insights into natural GH pulsatility, muscle protein synthesis, fat metabolism, and recovery enhancement. For researchers exploring the frontiers of endocrine optimization and performance physiology, Dragon Pharma’s tested GHRP-2 provides a reliable, potent foundation for groundbreaking growth hormone research.
GHRP-2 FAQ
While both are potent GH secretagogues, GHRP-2 causes significantly less hunger stimulation than GHRP-6, making it more suitable for cutting phase research or protocols where appetite control is important. GHRP-2 also demonstrates slightly different receptor binding characteristics that may result in more favorable cortisol and prolactin profiles.
Food intake, especially carbohydrates and fats, stimulates insulin release and increases somatostatin levels, both of which strongly suppress growth hormone secretion. Administering GHRP-2 on an empty stomach ensures maximal pituitary response by avoiding these natural GH inhibitors.
The substantial overfill means researchers are receiving approximately 17.6% more active peptide than labeled. For precise dosing, researchers should calculate based on the actual 5.88 mg content. For example, a 100 mcg dose would require drawing approximately 17.0 units instead of 20 units (based on standard reconstitution).
Yes, GHRP-2 is versatile for both research contexts. During cutting, it helps preserve lean mass while promoting fat utilization. During bulking with compounds like Testabol 400, it enhances nutrient partitioning and supports quality muscle growth through increased IGF-1 levels.
No traditional PCT is required as GHRP-2 stimulates your natural pituitary function rather than suppressing it. However, some researchers implement a gradual taper over 1-2 weeks to allow the hypothalamus-pituitary axis to smoothly return to baseline secretion patterns. For scientific context, see: National Library of Medicine – Growth Hormone.